| ISIN | CH0597699450 |
|---|---|
| Valor Number | 59769945 |
| Bloomberg Global ID | |
| Fund Name | GENERALI ESG Multi Asset Fund C |
| Fund Provider |
Generali Investments Schweiz AG
Soodmattenstrasse 2 8134 Adliswil 1 E-Mail: headoffice.ch@generali-invest.com Web: www.generali.ch/investments |
| Fund Provider | Generali Investments Schweiz AG |
| Representative in Switzerland |
Generali Investments Schweiz AG Adliswil 1 Phone: +41 58 472 44 44 |
| Distributor(s) |
Fortuna Investment AG Adliswil Generali Holding AG Adliswil Phone: +41 58 472 44 44 |
| Asset Class | Asset Allocation |
| EFC Category | |
| Distribution Policy | Accumulation |
| Home Country | Switzerland |
| Issuing Condition | The fund does not charge any issuing commission and/or fees (units are issued at the NAV) |
| Redemption Condition | The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV) |
| Investment Strategy *** | Das Anlageziel des GENERALI ESG Multi Asset Fund besteht da-rin, unter Berücksichtigung von Nachhaltigkeitskriterien, überwie-gend in Beteiligungswertpapiere und -rechte (Aktien, Genuss-scheine, Genossenschaftsanteile, Partizipationsscheine und ähn-liches) von weltweit tätigen Unternehmen und Forderungswertpa-piere und -rechte (Obligationen, Notes) von privatrechtlichen und öffentlich-rechtlichen Schuldnern zu investieren und dadurch das Fondsvermögen zu vermehren. |
| Peculiarities |
| Current Price * | 98.35 CHF | 10.12.2025 |
|---|---|---|
| Previous Price * | 98.59 CHF | 09.12.2025 |
| 52 Week High * | 102.14 CHF | 11.02.2025 |
| 52 Week Low * | 91.52 CHF | 11.04.2025 |
| NAV * | 98.35 CHF | 10.12.2025 |
| Issue Price * | ||
| Redemption Price * | ||
| Closing Price * | ||
| Indicative Minimum Price | ||
| Fund Assets *** | 6,429,912 | |
| Unit/Share Assets *** | 472,001 | |
| Trading Information SIX | ||
| YTD Performance | -0.63% |
31.12.2024 - 10.12.2025
31.12.2024 10.12.2025 |
|---|---|---|
| 1 month | -0.35% |
10.11.2025 - 10.12.2025
10.11.2025 10.12.2025 |
| 3 months | +0.38% |
10.09.2025 - 10.12.2025
10.09.2025 10.12.2025 |
| 6 months | +0.33% |
10.06.2025 - 10.12.2025
10.06.2025 10.12.2025 |
| 1 year | -1.29% |
10.12.2024 - 10.12.2025
10.12.2024 10.12.2025 |
| 2 years | +8.25% |
11.12.2023 - 10.12.2025
11.12.2023 10.12.2025 |
| 3 years | +9.49% |
12.12.2022 - 10.12.2025
12.12.2022 10.12.2025 |
| 5 years | -1.52% |
18.05.2021 - 10.12.2025
18.05.2021 10.12.2025 |
| Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI Date | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| International Bank for Reconstruction & Development 4.75% | 2.72% | |
|---|---|---|
| European Investment Bank 4.125% | 2.58% | |
| Inter-American Development Bank 3.875% | 2.30% | |
| Novartis AG Registered Shares | 2.12% | |
| SGS SA 2.3% | 1.75% | |
| Banco Santander, S.A. 2.24% | 1.75% | |
| ABB Ltd. 2.1125% | 1.74% | |
| Lonza Swiss Finanz AG 2.6% | 1.73% | |
| NVIDIA Corp | 1.73% | |
| Thermo Fisher Scientific Inc 2.0375% | 1.72% | |
| Last data update | 31.10.2025 | |
| TER | 1.55% |
|---|---|
| TER date | 30.09.2025 |
| Performance Fee *** | |
| PTR | |
| Max. Management Fee *** | 1.00% |
| Ongoing Charges *** | |
|
SRRI ***
|
|
| SRRI date *** | 30.11.2025 |